A user in their 50s expressed concern after two Ipamorelin cycles resulted in lower IGF-1 levels than their baseline measurements. Despite feeling fine, they noted that their physical gains in the gym had stalled and their last blood test showed a significant drop in IGF-1 shortly after finishing a cycle. The user questioned if the peptide could be suppressive or if the results were simply due to aging.